The Rare Cancer Research Foundation (RCRF) is a 501(c)3 dedicated to curing rare cancers through strategic investments and innovative collaborations that facilitate effective research and accelerate the deployment of promising therapies. Our key initiatives include pattern.org, the pattern data commons and the pattern biobank.
Precision Biosystems
Precision Biosystems is Massachusetts based company that provides instrumental solution to the difficult problems of laboratory automation. Precision Biosystems is a developer and manufacturer of a BlotCycler, an automated western blot processor, based on patented fluid distribution technology. All steps after protein transfer to a membrane are fully automated: shaking, blocking, hybridization, washing, and recycling of primary antibody. BlotCycler offers unique advantages over existing technologies in using immunoblotting for research and clinical work. Unique fluidic-based washing technology allows significant increase in sensitivity and requires less antibodies. The introduction of BlotCycler made consistent, reproducible, and high quality western blot a reality. Check our website: http://precisionbiosystems.com/freetrial/
Ohio State University Comprehensive Cancer Center-James Cancer Hospital & Solove Research Institute
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) is dedicated to creating a cancer-free world by integrating scientific research with excellence in education and patient-centered care – a strategy that leads to better methods of prevention, detection and treatment. Ohio State has been a National Cancer Institute (NCI)-designated Comprehensive Cancer Center for 50 years and is funded by the NCI to conduct phase I, II and III clinical trials on novel anticancer drugs provided by the NCI. As the cancer program’s adult patient-care component, The James is one of the top cancer hospitals in the nation as ranked by U.S. News & World Report and has achieved Magnet® recognition, the highest honor an organization can receive for quality patient care and professional nursing practice. With 21 floors, more than 1.1 million square feet and 378 inpatient beds, The James is the third-largest cancer hospital in the nation – a transformational facility that fosters collaboration and integration of cancer research and clinical cancer care.
NORD Rare Cancer Coalition
The Rare Cancer Coalition, formalized in 2017 as a program under the NORD Membership umbrella, unites advocacy organizations working in rare cancers to collaborate on issues facing their communities. Our goal is to eliminate the challenges faced by people affected by rare cancers through: Global awareness through campaigns such as #RareCancerDay, and representation at major events Publications and medical education Patient and caregiver education Collaborative networking and peer-to-peer mentoring Capacity building for Rare Cancer Patient Advocacy Groups
Night Science Institute
The Night Science Institute champions a cultural shift in science by training researchers to embrace the creative Night Science process as an essential complement to rigorous hypothesis testing.
National Cancer Institute
The National Cancer Institute (NCI) leads, conducts, and supports cancer research across the nation to advance scientific knowledge and help all people live longer, healthier lives.
Moffitt Cancer Center
Moffitt Cancer Center is dedicated to one lifesaving mission: to contribute to the prevention and cure of cancer. The Tampa-based facility is one of only 53 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt’s scientific excellence, multidisciplinary research, and robust training and education. Moffitt’s expert nursing staff is recognized by the American Nurses Credentialing Center with Magnet®️ status, its highest distinction. For more information, call 1-888-MOFFITT and or visit MOFFITT.org | Moffitt Cancer Center is dedicated to one lifesaving mission: to contribute to the prevention and cure of cancer. The Florida-based cancer center & research institute is one of only 57 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes scientific excellence, multidisciplinary research, and robust training and education. Moffitt’s expert nursing staff is recognized by the American Nurses Credentialing Center with Magnet® status, its highest distinction. Moffitt is ranked No. 10 in the nation and the top-ranked cancer hospital in Florida and the Southeast in Newsweek’s 2023 list of “America’s Best Cancer Hospitals.” Visit us at MOFFITT.org.
Memorial Sloan Kettering Cancer Center Therapeutics Accelerator
The MSK Therapeutics Accelerator is a strategic partnership program that connects MSK with biotechnology and pharmaceutical companies to advance novel cancer therapeutics through all stages of development. The program integrates MSK’s world-class scientific and clinical expertise with innovative company-led programs to establish collaborations that de-risk and accelerate the translation of discovery into patient benefit.
Medicines Discovery Catapult
About Medicines Discovery Catapult Medicines Discovery Catapult (MDC) is a national Life Sciences service dedicated to turning drug discovery into commercial breakthroughs. At the frontier of drug discovery, MDC works with entrepreneurial scientists to make every move count. It validates their ideas, de-risks investments, and feeds insights back into the sector to drive productivity and impact. MDC creates momentum through its unique blend of discovery expertise, technology, insights, and sector-leading partnerships. Where there is unmet patient need, MDC stimulates innovation through its National Programmes. MDC has worked with over 380 organisations, who have gone on to raise more than £1.8bn of R&D investment. Its approach to drug discovery drives game-changing breakthroughs and improves patients’ lives. More information: Part of the Innovate UK Catapult Network Based in Alderley Park, Cheshire For more information, visit https://md.catapult.org.uk/
Li Fraumeni Syndrome Association.org
We are a non profit patient advocacy organization dedicated to helping families with LFS worldwide.